New shot tested for kids with lupus
NCT ID NCT05917288
Summary
This study tested a version of the lupus drug belimumab given as an injection under the skin in Chinese children. It involved 16 children aged 5-17 who had already been receiving the drug by IV. The main goal was to measure how the drug behaved in the body at different weights and to check for side effects over 12 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Beijing, 100045, China
-
GSK Investigational Site
Changsha, 410007, China
-
GSK Investigational Site
Hangzhou, 310052, China
-
GSK Investigational Site
Nanjing, 210011, China
-
GSK Investigational Site
Shanghai, 361006, China
-
GSK Investigational Site
Suzhou, 215007, China
Conditions
Explore the condition pages connected to this study.